# Safety and Efficiency of γδ T Cell Against Lung Cancer

> **NCT03183232** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fuda Cancer Hospital, Guangzhou** · enrollment: 30 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **PROCEDURE:** Cryosurgery or IRE surgery
- **BIOLOGICAL:** γδ T cell
- **OTHER:** γδ T cells/ A Cryosurgery or IRE

## Key facts

- **NCT ID:** NCT03183232
- **Lead sponsor:** Fuda Cancer Hospital, Guangzhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2018-06-15
- **Final completion:** 2019-06-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183232, "Safety and Efficiency of γδ T Cell Against Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03183232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*